High Flow Nasal Cannula Versus Conventional Oxygen Therapy in Postoperative Patients at High Risk for Pulmonary Complications: A Systematic Review and Meta‐analysis
Guiling Xiang,Qiao Wu,Liang Xie,Jie Song,Xu Wu,Shengyu Hao,Ming Zhong,Shanqun Li
DOI: https://doi.org/10.1111/ijcp.13828
IF: 2.6
2020-01-01
International Journal of Clinical Practice
Abstract:International Journal of Clinical PracticeVolume 75, Issue 3 e13828 META-ANALYSIS High flow nasal cannula versus conventional oxygen therapy in postoperative patients at high risk for pulmonary complications: A systematic review and meta-analysis Gui-Ling Xiang, orcid.org/0000-0001-5293-2908 Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorQin-Han Wu, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorLiang Xie, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorJie-Qiong Song, Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorXu Wu, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorSheng-Yu Hao, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorMing Zhong, Corresponding Author zhong.ming@zs-hospital.sh.cn Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China Correspondence Ming Zhong, Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: zhong.ming@zs-hospital.sh.cn Shanqun Li, Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: li.shanqun@zs-hospital.sh.cnSearch for more papers by this authorShan-Qun Li, Corresponding Author li.shanqun@zs-hospital.sh.cn orcid.org/0000-0002-8096-9780 Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China Correspondence Ming Zhong, Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: zhong.ming@zs-hospital.sh.cn Shanqun Li, Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: li.shanqun@zs-hospital.sh.cnSearch for more papers by this author Gui-Ling Xiang, orcid.org/0000-0001-5293-2908 Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorQin-Han Wu, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorLiang Xie, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorJie-Qiong Song, Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorXu Wu, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorSheng-Yu Hao, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorMing Zhong, Corresponding Author zhong.ming@zs-hospital.sh.cn Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China Correspondence Ming Zhong, Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: zhong.ming@zs-hospital.sh.cn Shanqun Li, Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: li.shanqun@zs-hospital.sh.cnSearch for more papers by this authorShan-Qun Li, Corresponding Author li.shanqun@zs-hospital.sh.cn orcid.org/0000-0002-8096-9780 Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China Correspondence Ming Zhong, Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: zhong.ming@zs-hospital.sh.cn Shanqun Li, Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. Email: li.shanqun@zs-hospital.sh.cnSearch for more papers by this author First published: 09 November 2020 https://doi.org/10.1111/ijcp.13828 Gui-Ling Xiang and Qin-Han Wu contributed equally to this work. Funding information: This work was supported by grants from the National Key Research and Development Program of China (No. 2018YFC1313600) and the National Natural Science Foundation of China (No. 82070094, 81570081, 81770083). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Abstract Background The effects of high flow nasal cannula (HFNC) on postoperative patients at high risk for pulmonary complications(PC) are controversial. We aimed to further determine the effectiveness of HFNC in postoperative patients at high risk for PC by comparison to conventional oxygen therapy (COT). Methods We performed a comprehensive search that compared HFNC with COT in postoperative patients at high risk for PC. The main outcomes were length of hospital stay (hospital LOS) and respiratory complications. Results Six trials with a total of 733 patients were pooled in our final studies. Except for Hospital LOS (I2 = 53%, χ2 = 8.51, P = .07) and rate of intubation or non-invasive ventilation (NIV) for respiratory failure (RF) (I2 = 49%, χ2 = 1.97, P = .16) between HFNC and COT, no significant heterogeneity was found in outcome measures. Compared with COT, HFNC was associated with a lower rate of intubation or NIV for RF (RR 0.23, 95% CI 0.08-0.66, P = .006) and rate of hypercapnia (RR 0.37, 95% CI 0.20-0.68, P = .002). As for the Hospital LOS, ICU LOS, rate of requirement of O2 after discontinuous and hypoxemia, HFNC did not show any advantage over COT. Trial Sequential Analysis (TSA) for Hospital LOS showed that monitoring boundaries were finally not surpassed and required information size (RIS) was not met. Conclusions The available randomised controlled trials (RCTs) suggest that, among the postoperative patients at high risk for PC, HFNC therapy compared with the COT significantly reduces rate of incubation or NIV for RF and rate of hypercapnia, meanwhile is safely administered. Further large-scale, multicenter, randomised and controlled studies are needed to confirm our results. Open Research DATA AVAILABILITY STATEMENT The data that support the findings of this study are available on request from the corresponding author upon reasonable request. Supporting Information Filename Description ijcp13828-sup-0001-TablesS1.docxWord document, 85.9 KB Tables S1 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume75, Issue3March 2021e13828 RelatedInformation